188 related articles for article (PubMed ID: 22150747)
21. Animal models of transfusion-related acute lung injury.
Looney MR; Matthay MA
Crit Care Med; 2006 May; 34(5 Suppl):S132-6. PubMed ID: 16617257
[TBL] [Abstract][Full Text] [Related]
22. Diagnosis of transfusion-related acute lung injury: TRALI or not TRALI?
Fontaine MJ; Malone J; Mullins FM; Grumet FC
Ann Clin Lab Sci; 2006; 36(1):53-8. PubMed ID: 16501237
[TBL] [Abstract][Full Text] [Related]
23. AABB survey of transfusion-related acute lung injury policies and practices in the United States.
Kopko P; Silva M; Shulman I; Kleinman S
Transfusion; 2007 Sep; 47(9):1679-85. PubMed ID: 17725734
[TBL] [Abstract][Full Text] [Related]
24. Leucocyte antibodies in blood donors and a look back on recipients of their blood components.
Maślanka K; Michur H; Zupańska B; Uhrynowska M; Nowak J
Vox Sang; 2007 Apr; 92(3):247-9. PubMed ID: 17348874
[TBL] [Abstract][Full Text] [Related]
25. The impact of policies to restrict the use of plasma containing products and apheresis platelets from female donors to mitigate transfusion related acute lung injury (TRALI) in Brazil.
Blatyta PF; Custer B; Liu J; Mendrone-Junior A; Wright DJ; Leão SC; Lopes MI; Carneiro-Proietti AB; Sabino EC; de Almeida-Neto C;
Transfus Apher Sci; 2013 Feb; 48(1):15-20. PubMed ID: 22985535
[TBL] [Abstract][Full Text] [Related]
26. Transfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusion.
Bux J
Vox Sang; 2005 Jul; 89(1):1-10. PubMed ID: 15938734
[TBL] [Abstract][Full Text] [Related]
27. The pathogenesis of transfusion-related acute lung injury (TRALI).
Bux J; Sachs UJ
Br J Haematol; 2007 Mar; 136(6):788-99. PubMed ID: 17341264
[TBL] [Abstract][Full Text] [Related]
28. TRALI due to granulocyte-agglutinating human neutrophil antigen-3a (5b) alloantibodies in donor plasma: a report of 2 fatalities.
Davoren A; Curtis BR; Shulman IA; Mohrbacher AF; Bux J; Kwiatkowska BJ; McFarland JG; Aster RH
Transfusion; 2003 May; 43(5):641-5. PubMed ID: 12702187
[TBL] [Abstract][Full Text] [Related]
29. [Pathogenetic analysis of transfusion-related acute lung injury caused by human leukocytes antigen antibody against human leukocyte antigen].
Deng J; Xu XZ; Ye X; Chen YK; Ding HQ; Liu J; Xia WJ; Chen DW; Xu YR
Zhonghua Yi Xue Za Zhi; 2024 Mar; 104(11):883-887. PubMed ID: 38462366
[TBL] [Abstract][Full Text] [Related]
30. Comparison of acute non-haemolytic transfusion reactions in female and male patients receiving female or male blood components.
Imoto S; Araki N; Shimada E; Saigo K; Nishimura K; Nose Y; Bouike Y; Hashimoto M; Mito H; Okazaki H
Transfus Med; 2007 Dec; 17(6):455-65. PubMed ID: 18067650
[TBL] [Abstract][Full Text] [Related]
31. Long-term in vitro reactivity for human leukocyte antigen antibodies and comparison of detection using serum versus plasma.
Norris PJ; Lee JH; Carrick DM; Gottschall JL; Lebedeva M; de Castro BR; Kleinman SH; Busch MP
Transfusion; 2009 Feb; 49(2):243-51. PubMed ID: 18980615
[TBL] [Abstract][Full Text] [Related]
32. Transfusion-related acute lung injury due to HLA-A2-specific antibodies in recipient and NB1-specific antibodies in donor blood.
Bux J; Becker F; Seeger W; Kilpatrick D; Chapman J; Waters A
Br J Haematol; 1996 Jun; 93(3):707-13. PubMed ID: 8652399
[TBL] [Abstract][Full Text] [Related]
33. Recurrent transfusion-related acute lung injury.
Win N; Montgomery J; Sage D; Street M; Duncan J; Lucas G
Transfusion; 2001 Nov; 41(11):1421-5. PubMed ID: 11724989
[TBL] [Abstract][Full Text] [Related]
34. A preliminary comparison of the prevalence of transfusion reactions in recipients of platelet components from donors with and without human leucocyte antigen antibodies.
Fadeyi EA; Adams S; Sheldon S; Leitman SF; Wesley R; Klein HG; Stroncek DF
Vox Sang; 2008 May; 94(4):324-8. PubMed ID: 18282262
[TBL] [Abstract][Full Text] [Related]
35. Transfusion-related acute lung injury associated with interdonor incompatibility for the neutrophil-specific antigen HNA-1a.
Lucas G; Rogers S; Evans R; Hambley H; Win N
Vox Sang; 2000; 79(2):112-5. PubMed ID: 11054050
[TBL] [Abstract][Full Text] [Related]
36. [Transfusion-related lung injury edema].
Fruchart MF; Klaren J; Belhocine R; Ben Hadj Amor H
Rev Med Interne; 1999 Sep; 20(9):781-4. PubMed ID: 10522300
[TBL] [Abstract][Full Text] [Related]
37. Prevalence of HLA sensitization in female apheresis donors.
Densmore TL; Goodnough LT; Ali S; Dynis M; Chaplin H
Transfusion; 1999 Jan; 39(1):103-6. PubMed ID: 9920173
[TBL] [Abstract][Full Text] [Related]
38. Donor risk factors for white blood cell antibodies associated with transfusion-associated acute lung injury: REDS-II leukocyte antibody prevalence study (LAPS).
Triulzi DJ; Kakaiya R; Schreiber G
Transfusion; 2007 Apr; 47(4):563-4. PubMed ID: 17381611
[No Abstract] [Full Text] [Related]
39. Donor antibodies to HNA-3a implicated in TRALI reactions prime neutrophils and cause PMN-mediated damage to human pulmonary microvascular endothelial cells in a two-event in vitro model.
Silliman CC; Curtis BR; Kopko PM; Khan SY; Kelher MR; Schuller RM; Sannoh B; Ambruso DR
Blood; 2007 Feb; 109(4):1752-5. PubMed ID: 17038531
[TBL] [Abstract][Full Text] [Related]
40. [TRALI: from diagnosis to prevention].
Muller JY
Transfus Clin Biol; 2005 Jun; 12(2):95-102. PubMed ID: 15894508
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
